Projects:DiffusionImageAnalysisGenetics - Revision history

Melonakos at 18:37, 2 April 2008

2008-04-02T18:37:16Z

2008-01-06T03:53:45Z

2007-12-21T03:13:31Z

2007-12-12T18:04:21Z

2007-11-27T18:44:45Z

2007-09-04T14:20:08Z

2007-09-04T13:08:52Z

2007-09-04T12:58:37Z

2007-09-03T18:08:58Z

2007-08-21T16:25:51Z

@@ Line 1: / Line 1: @@
-  Back to [[NA-MIC_Internal_Collaborations|NA-MIC Collaborations]], [[DBP1:Toronto|Toronto DBP 1]], [[DBP1:Harvard|Harvard DBP 1]], [[DBP2:Harvard|Harvard DBP 2]]
+  Back to [[DBP1:Toronto|Toronto DBP 1]], [[DBP1:Harvard|Harvard DBP 1]], [[DBP2:Harvard|Harvard DBP 2]]
 __NOTOC__
 = A DTI and Genetics Study of Psychosis Across the Lifespan =

@@ Line 1: / Line 1: @@
-  Back to [[NA-MIC_Collaborations|NA-MIC_Collaborations]], [[DBP1:Toronto|Toronto DBP 1]]
+  Back to [[NA-MIC_Internal_Collaborations|NA-MIC Collaborations]], [[DBP1:Toronto|Toronto DBP 1]], [[DBP1:Harvard|Harvard DBP 1]], [[DBP2:Harvard|Harvard DBP 2]]
 __NOTOC__
 = A DTI and Genetics Study of Psychosis Across the Lifespan =
@@ Line 14: / Line 14: @@
 = Key Investigators =
-* Toronto: Aristotle Voineskos, Nancy Lobaugh, Benoit Mulsant, Bruce Pollock, James Kennedy,
+* Toronto DBP 1: Aristotle Voineskos, Nancy Lobaugh, Benoit Mulsant, Bruce Pollock, James Kennedy,
-* BWH: Marek Kubicki, Martha Shenton
+* Harvard DBP 1: Martha Shenton

@@ Line 1: / Line 1: @@
-  Back to [[NA-MIC_Collaborations|NA-MIC_Collaborations]]
+  Back to [[NA-MIC_Collaborations|NA-MIC_Collaborations]], [[DBP1:Toronto|Toronto DBP 1]]
-__TOC__
+__NOTOC__
 = A DTI and Genetics Study of Psychosis Across the Lifespan =

@@ Line 1: / Line 1: @@
 = A DTI and Genetics Study of Psychosis Across the Lifespan =
-  Back to [[NA-MIC_Collaborations|NA-MIC_Collaborations]]
+Here write a brief overview of your project.
-−
-'''Objectives'''
+= Description =
 # Use of Diffusion Tensor Imaging (DTI) to determine white matter differences between psychosis (schizophrenia, schizoaffective, etc.) patients and healthy controls across the lifespan
 # Measure the effect of myelin system genes on FA
 participants with psychosis and 10 healthy controls have been recruited to date
-''References''
+= Key Investigators =
 * Toronto: Aristotle Voineskos, Nancy Lobaugh, Benoit Mulsant, Bruce Pollock, James Kennedy,
 * BWH: Marek Kubicki, Martha Shenton

@@ Line 5: / Line 5: @@
 '''Objectives'''
-#Use of Diffusion Tensor Imaging (DTI) to determine white matter differences between psychosis (schizophrenia, schizoaffective, etc.) patients and healthy controls across the lifespan
+# Use of Diffusion Tensor Imaging (DTI) to determine white matter differences between psychosis (schizophrenia, schizoaffective, etc.) patients and healthy controls across the lifespan
-#Measure the effect of myelin system genes on FA
+# Measure the effect of myelin system genes on FA
 '''Progress'''

@@ Line 16: / Line 16: @@
 '''Key Investigators:'''
-* Toronto:Aristotle Voineskos, Nancy Lobaugh, Benoit Mulsant, Bruce Pollock, James Kennedy,
+* Toronto: Aristotle Voineskos, Nancy Lobaugh, Benoit Mulsant, Bruce Pollock, James Kennedy,
 * BWH: Marek Kubicki, Martha Shenton

← Older revision		Revision as of 16:25, 21 August 2007
Line 1:		Line 1:
		+	Back to [[NA-MIC_Collaborations\|NA-MIC_Collaborations]]
		+
	'''Objectives:'''		'''Objectives:'''
	#Use of Diffusion Tensor Imaging (DTI) to determine white matter differences between psychosis (schizophrenia, schizoaffective, etc.) patients and healthy controls across the lifespan		#Use of Diffusion Tensor Imaging (DTI) to determine white matter differences between psychosis (schizophrenia, schizoaffective, etc.) patients and healthy controls across the lifespan